ABSTRACT
An
amino acid, vitamin, and mineral formulation, was designed to restore
catecholaminergic, opioidergic, GABAergic, and serotonergic deficits
observed in individuals suffering from long-term, moderate-to-high
emotional stressors. Researchers under the direction of Dr. Neher,
examined the effects such a stress formulation might have on the
stressors associated with the outpatient in alcohol and other chemical
addiction recovery. Two hundred eighty-five (285) self admitted
outpatients were involved in a two year long controlled study. During
this period, 100 patients began the program who did not take any
amino acid supplements. Nine (9) of this “control” group dropped
out before the program was completed. Of the 91 non-amino acid patients
remaining, 78 reported 1 to 5 incidents of alcohol or drug use.
An additional 185 patients regularly consumed an amino acid supplement
designed for those in high stress situations. All but 3 of these
remained in the program and NONE reported relapses. Thus the control
group reported a 9% drop out rate and an 86% relapse rate compared
to the experimental groups 1.6% drop out and 0% relapse. The only
factor common to all who reported relapses, was NOT using the amino
acid supplements.
INTRODUCTION
Professionals
in the field of Chemical Dependency realize addiction has little
to do with will power or moral character. Until recently, however,
we have not had the advantage of research that is now clarifying
susceptibility factors leading to dependencies.
We
have known that abnormal neurochemistries occur as a result of genetic
factors and we are being shown more definitely just what they might
be. We now realize that environmental stressors, dysfunctional family
stressors, and unhealthy behaviors, also, result in neurochemical
alterations and depletions. These altered chemical states are the
antecedents or factors necessary for a person to receive positive
reinforcement through the use of chemicals.
The
way we think, feel, and act all happen because of chemical reactions
and interactions in our brains. These chemical reactions are dependent
upon balanced levels of many separate chemical molecules working
together with specialized brain cells to produce thoughts, feelings
and actions. For every thought, feeling, and behavior there exists
a neurochemical equivalent in the brain. A person who uses external
source chemistries to gain desired thoughts, feelings, or behaviors,
becomes “chemically dependent.” In other words, for a person to
become dependent on an external source chemical to produce desired
results, there must first exist or be developed, a deficiency of
a chemical component in the brain. Initially then, abstinence results
in a dramatically curtailed brain chemistry, and consequently the
person experiences impaired thinking, irrational feelings, and unacceptable
behaviors as he/she attempts to interact in society with diminished
neurochemical availability.
These
altered states DO NOT automatically or quickly readjust or repair
without neuronutrient intervention. The use of antidepressants,
for instance, may be ineffective due to a lack of neurotransmitter
availability upon which to act.
Neurochemical
alteration is the rationale for physiologic stabilization as the
necessary starting focus for recovery. This has also been lacking
in many treatment modalities until recently. In 1989, we suggested
to a patient in the chronic stage of alcoholism that he use certain
“health food” products in an attempt to relieve the anxiety and
depression he was experiencing as a result of stopping the daily
use of alcohol. Within 5 days he was less anxious and less depressed,
and sensed no imperative to change the way he felt. On numerous
occasions this individual had gone without alcohol for 7 to 10 days,
but suffered continued anxiety and always returned to drinking.
Today he has been sober 4 years without a single reported relapse.
So
impressive was this demonstration that we quickly expanded the approach
to more patients. All reported similar results. At about the same
time Blum and associates, in a series of papers, reported their
findings involving utilization of neuronutrient combinations for
precursor loading to enhance neurotransmitter availability (Blum,
1989). Because the combination of ingredients made it possible to
purchase the desired amino acids in a single bottle, the researchers
felt the patients would be more apt to utilize them. This proved
to be true. (Structure in early recovery is not an easy task.)
We
were very encouraged with the rapidity of stabilization taking place
in our patients. It suddenly became much more simple to build trust,
discuss issues, and apply solutions. Apparently their brains were
beginning to function once again. These open trial results begged
further study.
SUBJECTS
AND METHOD
The
effort that followed was not originally organized as a scientific
study. By happenstance, however, a control group quickly emerged
from those patients who chose not to use the suggested amino acid
regimen. The patients involved consisted of approximately 90% alcoholics
and 10% cocaine and other drug dependent subjects attending a one-year
outpatient treatment programs at the Colonial Clinic, Spokane, Washington.
For the most part these outpatients were self-referred and had a
wide variety of socioeconomic backgrounds. All patients received
education concerning the potential benefits of aminoacid therapy.
Selection of amino-acids appeared to be economic rather than any
other criteria. As we watched these two groups of outpatients, it
became obvious that the alcoholics using the neuronutrient stabilized
within 3 days to a level of calmness they had not experienced in
years, if ever. Those cocaine addicts using the neuronutrient were
able to get past their usual days of purchase without significant
anxiety induced stress -- and this was in outpatient treatment!
We
decided to follow our entire patient population and attempt to extract
significant relapse information over a 2-year period. We chose 4
factors as significant in relapse prevention:
- 1.
Had the patient developed and utilized a daily recovery plan?
- 2.
Was the patient utilizing amino acid supplements as suggested?
- 3.
Was the patients’ family involved in recovery?
- 4.
Was the patient attending outside support group?
As
shown in Figure 1, we followed 260 patients in an outpatient modality
for 730 days. During this period, out of 91 patients who were not
taking any amino acid supplements, 78 reported one to five incidents
of alcohol or drug use; the 182 patients on amino acid supplements
reported NO relapses. The relapse rates were estimated to be
86% for the nonamino acid therapy group compared to 0% for the amino
acid therapy group.
The only factor common to all who left the program or reported relapses
was that the patient was NOT using the recommended amino acid supplements.
These supplements were, of course, designed to provide precursor
building blocks for the neurotransmitters most effected by the stress
of recovery. We further interpreted this to mean: No one using amino
acid supplements, as suggested, had relapsed in a two year period.
Colonial
Clinic continues to use the same amino acid regimen today1 with
very similar results. The rationale for the use of carefully formulated
supplements is logical and, based on our experience, should become
the standard for stabilization and early recovery (at least one
year.) Patients want to feel positive, calm and complete WITHOUT
the use of drugs. Supplementation with neuronutrients for precursor
loading allows this to happen naturally, encouraging normal brain
function and involving the patient in a healthy way in his/her recovery.
FORMULAS
(per capsule) USED: |